← Eichor
Condition: Leukocyte Disorder Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Leukocyte Disorder

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia
Phase 1 · 1 location(s) · Union Hospital, Tongji Medical College, Huazhong University · NCT06245746Predictive Signature of Benralizumab Response
Phase 4 · 20 location(s) · Nantes University Hospital · NCT04565483A Single-arm, Dose-escalation Trial of Long-acting Recombinant Human IL-7 (NT-I7, Efineptakin Alfa) for Idiopathic CD4 L
Phase 1/Phase 2 · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT05600920Collection of Lung Fluid and Tissue Samples for Research
Phase N/A · 1 location(s) · National Heart, Lung, and Blood Institute (NHLBI) · NCT00471250Prospective Registry of EoSinophilic esOphagitis
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT06443346Natural History, Management, and Genetics of the Hyperimmunoglobulin E Recurrent Infection Syndrome (HIES)
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00006150Evaluation of the Effect of Cordycepin on CD8+ Lymphocytopenia in Patients With Solid Tumors
Phase 2 · 1 location(s) · Second Affiliated Hospital of Soochow University · NCT07258160Esophageal String Test Monitoring to Monitor Eosinophilic Esophagitis During Oral Immunotherapy
Phase N/A · 1 location(s) · Children's Hospital of Philadelphia · NCT06389994A Non-interventional, Prospective Study With Benralizumab
Phase N/A · 41 location(s) · AstraZeneca · NCT06422078The Esophageal String Test as a Diagnostic Screening Tool for Eosinophilic Esophagitis Among Africans With Dysphagia in
NA · 3 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT07027826Cologne Cohort of Neutropenic Patients (CoCoNut)
Phase N/A · 1 location(s) · University Hospital of Cologne · NCT01821456Mechanisms Underlying Impaired Diabetic Wound Healing
Phase N/A · 2 location(s) · University of Pittsburgh · NCT00777712Short Antibiotic Treatment in High Risk Febrile Neutropenia
NA · 4 location(s) · University Health Network, Toronto · NCT05786495Immunological Effects of Iron Supplementation in HHT Disease
NA · 1 location(s) · Hospices Civils de Lyon · NCT07111598Eosinophilic Gastrointestinal Disorders Registry
Phase N/A · 1 location(s) · Ann & Robert H Lurie Children's Hospital of Chicago · NCT05199532Next-Generation-Sequencing Approach to Neutropenic Sepsis
Phase N/A · 6 location(s) · Boris Böll · NCT05815628Prospective Registry of Eosinophilia With Respiratory Manifestations With Translational Research Identifying and Charact
Phase N/A · 1 location(s) · Medical University Innsbruck · NCT04538937Pediatric Eosinophilic Esophagitis (pedEoE): Effect of Allergen Heat Denaturation on EoE Remission: a Pilot Trial
NA · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT06381219Clinical Study of Thiopegfilgrastim for Preventing Bone Marrow Suppression in Thoracic Tumor Chemoradiotherapy
Phase 2 · 1 location(s) · Affiliated Hospital of Nantong University · NCT07205536A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis
Phase 3 · 11 location(s) · Regeneron Pharmaceuticals · NCT07112378Prevalence of Ethnic Neutropenia and Duffy Null Phenotype in Neonates
Phase N/A · 1 location(s) · Kaplan Medical Center · NCT06908616Luspatercept for Clonal Cytopenias of Uncertain Significance
Phase 2 · 1 location(s) · Weill Medical College of Cornell University · NCT06788691Lentiviral Gene Therapy for CGD
NA · 1 location(s) · Shenzhen Geno-Immune Medical Institute · NCT03645486Phase II Study of QLC2519 in Pediatric Solid Tumor Participants
Phase 2 · 1 location(s) · Qilu Pharmaceutical Co., Ltd. · NCT07724756A Study of KT-621 Administered Orally to Adult Participants With Moderate to Severe Eosinophilic Asthma
Phase 2 · 58 location(s) · Kymera Therapeutics, Inc. · NCT07323654Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease
Phase N/A · 52 location(s) · Ensoma · NCT06605378Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysp
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT02115295Analysis of the Immunobiology of Acute Myeloid Leukemia Relapses After Allogeneic Hematopoietic Stem Cell Transplant (HS
Phase N/A · 1 location(s) · Ciceri Fabio · NCT05124288Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and Granulocytes
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT00001405Diagnostic Performance of Artificial Intelligence Algorithms in Prediction of Acute Coronary Syndrome Based on White Blo
Phase N/A · 1 location(s) · RobotDreams GmbH · NCT06384846
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.